- 掃描二維碼關(guān)注儀器無(wú)憂網(wǎng)微信公眾平臺(tái)
- 您可以獲得:
- 1.更高效的咨詢方式
- 2.更便利的瀏覽體驗(yàn)
- 3.實(shí)時(shí)的動(dòng)態(tài)信息獲取
- 儀器無(wú)憂網(wǎng)
- 服務(wù)中心
Fresenius
Fresenius Biotech
德國(guó)Fresenius Biotech www.fresenius-biotech.com
費(fèi)森尤斯生物技術(shù):生物制藥產(chǎn)品的開(kāi)發(fā)及銷售,主要應(yīng)用于基因、腫瘤、移植和再生醫(yī)學(xué)領(lǐng)域。
Fresenius Biotech is dedicated to delivering innovative therapeutics to patients with serious illnesses that have a high degree of unmet need. A focal point of our activities is the development of immunotherapeutic products based on innovative antibody technologies. Our focused approach to research and development combined with our international marketing experience enables us to efficiently bring targeted therapeutics to a global patient population.
Our main areas of research:
Transplantation
Oncology
Our core competencies:
Preclinical research and clinical development
Worldwide registration of biopharmaceuticals
Innovative marketing for specialized indications
Attaining market access for innovative products
Founded in 2003, Fresenius Biotech employs approx. 170 employees in Europe and the USA. Fresenius Biotech is a subsidiary of the Fresenius SE healthcare group.